City

Bethesda (1)

Petah tikva (1)

Overall Status

Recruiting (1)

Unknown status (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Connecticut Children's Medical Center (1)

National Human Genome Research Institute (NHGRI) (1)

Rabin Medical Center (1)

Collaborator

DuPont Nutrition and Health (1)

Duke University (1)

Merck Sharp & Dohme LLC (1)

University of Massachusetts, Worcester (1)

Intervention

canakinumab (1)

lactobacillus acidophilus and bifidobacterium lactis (1)

placebo (1)

Study Documents

Intervention Type

biological (1)

drug (1)

other (1)

Funder Type

Other (2)

NIH (1)

Study Type

Interventional (2)

Observational (1)

periodic fever

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Disorders: Genetics and Disease Characteristics

Recruiting

Familial Mediterranean Fever (FMF)
+6 more

Bethesda, Maryland

National Institutes of Health Clinical Center

Jan 21, 2023

Periodic Fever Trial in Petah tikva (Canakinumab)

Unknown status

Periodic Fever

Canakinumab

Petah tikva, Israel

SCMCI

Aug 30, 2018

Periodic Fever, Aphthous Stomatitis, Pharyngitis Trial (Lactobacillus acidophilus and Bifidobacterium lactis, Placebo)

Withdrawn

Periodic Fever
+3 more

Lactobacillus acidophilus and Bifidobacterium lactis
Placebo

(no location specified)

Jan 23, 2018